The trajectory of copyright's flagship drug presents a interesting case for investors in the medicinal sector. While initially a phenomenal success, producing huge profits, the patent expiration and the subsequent https://pharma571456.loginblogin.com/49962314/sildenafil-and-pharma-a-hazardous-investment